Edible mushrooms as potential functional foods in amelioration of hypertension
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7865 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2023. Written by Abdur Rauf and 7 co-authors. Institution: Department of Chemistry, University of Swabi, Swabi, Pakistan. Major MEDLINE topics: Agaricales, Hypertension, Cardiovascular Diseases. Cited 52 times so far (Crossref); 149 references. The full text is freely available (open access, CC BY 4.0). Funded by: Universidade de Vigo.
Abstract (original language)
Edible mushrooms are popular functional foods attributed to their rich nutritional bioactive constituent profile influencing cardiovascular function. Edible mushrooms are omnipresent in various prescribed Dietary Approaches to Stop Hypertension, Mediterranean diet, and fortified meal plans as they are rich in amino acids, dietary fiber, proteins, sterols, vitamins, and minerals. However, without an understanding of the influence of mushroom bioactive constituents, mechanism of action on heart and allergenicity, it is difficult to fully comprehend the role of mushrooms as dietary interventions in alleviating hypertension and other cardiovascular malfunctions. To accomplish this endeavor, we chose to review edible mushrooms and their bioactive constituents in ameliorating hypertension. Hypertension and cardiovascular diseases are interrelated and if the former is managed by dietary changes, it is postulated that overall heart health could also be improved. With a concise note on different edible varieties of mushrooms, a particular focus is presented on the antihypertensive potential of mushroom bioactive constituents, mode of action, absorption kinetics and bioavailability. Ergosterol, lovastatin, cordycepin, tocopherols, chitosan, ergothioneine, γ‐aminobutyric acid, quercetin, and eritadenine are described as essential bioactives with hypotensive effects. Finally, safety concerns on allergens and limitations of consuming edible mushrooms with special reference to chemical toxins and their postulated metabolites are highlighted. It is opined that the present review will redirect toxicologists to further investigate mushroom bioactives and allergens, thereby influencing dietary interventions for heart health.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Chemistry, University of Swabi, Swabi, Pakistan.
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Operations and Method Development, Shefali Research Laboratories, Ambernath, India.
- Department of Medical Laboratory Technology, College of Applied Medical Sciences, Taibah University, Al Madinah Al Munawwarah, Saudi Arabia.
- Department of Medical Biochemistry, Abubakar Tafawa Balewa University, Bauchi, Nigeria.
- Department of Biotechnology, Bacha Khan University, Khyber Pakhtunkhwa, Pakistan.
ORCID profiles: Abdur Rauf, Payal B Joshi, Zubair Ahmad, Hassan A Hemeg, Ahmed Olatunde, Saima Naz, Nabia Hafeez, Jesus Simal-Gandara
Funding
- Universidade de Vigo
Cite
APA
Rauf, A., Joshi, P. B., Ahmad, Z., Hemeg, H. A., Olatunde, A., Naz, S., Hafeez, N., & Simal-Gandara, J. (2023). Edible mushrooms as potential functional foods in amelioration of hypertension. Phytotherapy Research. https://doi.org/10.1002/ptr.7865
Vancouver
Rauf A, Joshi PB, Ahmad Z, Hemeg HA, Olatunde A, Naz S, et al. Edible mushrooms as potential functional foods in amelioration of hypertension. Phytotherapy Research. 2023. doi:10.1002/ptr.7865
BibTeX
@article{Rauf2023,
author = {Rauf, Abdur and Joshi, Payal B and Ahmad, Zubair and Hemeg, Hassan A and Olatunde, Ahmed and Naz, Saima and Hafeez, Nabia and Simal-Gandara, Jesus},
title = {Edible mushrooms as potential functional foods in amelioration of hypertension},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7865}
}
EUVIMED